IgG to Borrelia burgdorferi (Lyme disease antibody)
This test measures the presence of antibodies in your blood that your immune system produces in response to *Borrelia burgdorferi*, the bacterium responsible for Lyme disease.
["Helps diagnose Lyme disease by detecting your immune system’s reaction to the infection."]
Key facts at a glance
- LOINC
- 111306-7
- Short code
- COXPH1M
- Synonyms
- C burnet Ph1 IgM Msmt Ser
- Category
- chemistry
- Sample
- serum
- Container
- Serum separator tube (SST) or red-top clot activator tube
- Units
- N/A
- Ref low
- 0
- Ref high
- 1
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Enzyme-linked immunosorbent assay (ELISA) or Indirect Immunofluorescence Assay (IFA) for detection of IgM antibodies against Coxiella burnetii phase I antigen
- CPT
- 86638
- SNOMED
- 313327003
- Specimen volume
- 1-2 mL serum
- Stability
- Serum stable for 7 days at 2-8°C; for extended storage, freeze at -20°C or below. Avoid repeated freeze-thaw cycles.
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 24–72 hours
- Order
- routine
What This Test Measures
The test looks for IgG antibodies against *Borrelia burgdorferi*, a bacterium transmitted primarily through tick bites. These antibodies indicate whether your body has been exposed to the bacteria at some point, even if symptoms have already cleared or the infection is in an early stage.
Why It’s Ordered
Your healthcare provider may order this test if you have symptoms of Lyme disease (e.g., rash, joint pain, fatigue) or if you’ve been in an area with high tick activity. It’s also used to monitor treatment effectiveness or check for past exposure.
How the Test Works
Blood is drawn and tested using an immunoassay method to detect IgG antibodies specific to *Borrelia burgdorferi*. This method identifies whether your immune system has recognized and fought the bacteria.
What to Expect Before the Test
No special preparation is needed. You may eat and drink normally, but inform your provider if you’re on blood-thinning medications or have a bleeding disorder.
Reference range
Negative: <1:16 titer or below assay-specific cutoff (varies by laboratory). Equivocal/Positive: ≥1:16 or above assay cutoff. A fourfold rise in titer between acute and convalescent sera confirms recent infection.N/A
No fasting required. Patient should inform clinician of recent antibiotic use, vaccination history (e.g., Q fever vaccine), occupational exposure to livestock, and travel history. Acute and convalescent serum samples (2-4 weeks apart) are recommended for accurate diagnosis.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Short name
IgG Antibody to Borrelia burgdorferi
Frequently asked questions
IgG antibodies to *Borrelia burgdorferi* can appear weeks to months after infection, even if symptoms have resolved. While they don’t always confirm active Lyme disease, they suggest past exposure. False positives can occur in rare cases, so results should be interpreted by a healthcare provider in the context of symptoms and clinical history.
Can this test detect Lyme disease if I’ve already been treated?
What if my test results are positive but I don’t have symptoms?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy